hospitalization preferable? What can be done in a hospital that cannot be done in a clinic or physician's office? What can be done more effectively (more quickly, less expensively) in a hospital? Although coexistent diseases may require hospitalization, when does a patient suffering solely from tuberculosis need to be hospitalized?
Recommendations and Rationale
It is not uncommon for a patient to be diagnosed as having tuberculosis while in the hospital. Symptoms of his tuberculosis may have led to his admission, or he may have another disease and be found incidentally to have tuberculosis. In the latter case the stay in the hospital would be determined by the primary disease. The indications for admission or continued stay in the hospital related to tuberculosis itself are like those for any other disease. They include potentially life-threatening conditions such as miliarylmeningeal disease, adult respiratory distress syndrome, intravascular coagulation, hemoptysis, or severe reactions to drugs.
Tuberculous patients were once confined to the hospital to avoid the spread of infection in the community. The advent of effective chemotherapy and the subsequent conversion of tuberculosis hospitals to use as general hospitals altered the situation. Infectiousness is not now, in itself, an indication for confinement in the hospital, except in those rare cases where social circumstances or drug-resistant organisms pose special risks to the community. For those patients who are in a hospital, measures including effective chemotherapy, covering the mouth when coughing, and placement in private rooms with appropriate ventilation are all that is necessary to reduce the potential for transmission of infection. Available information shows that with these precautions, the risk of infection to the hospital's staff or other patients is very low. Elaborate additional procedures for isolation frequently inhibit appropriate contact with the hospital's personnel and others and should be avoided.
Finally, when a diagnosis is not readily accomplished on an outpatient basis or when a patient's life is disorganized to the extent that his needs cannot otherwise be met, hospitalization will be necessary.
Acquired drug resistance continues to occur in some persons with tuberculosis because of poor compliance or the prescription of inappropriate regimens of therapy. Primary drug resistance occurs in individuals who have not received any previous treatment for tuberculosis. The occurrence of primary drug resistance is usually considered an indication of transmission of drug-resistant organisms from patients with acquired drug resistance who have received inadequate or inappropriate therapy. In the United States, about 7 percent of the previously untreated cases have organisms resistant to one or more antituberculosis drugs. Rates of primary drug resistance have been decreasing in recent years, but drug resistance remains a problem in some geographic areas and in certain population groups such as Asians and Hispanics. Early studies in animals and the absence of community outbreaks of drug-resistant tuberculosis initially lead many observers to conclude that drug-resistant tuberculous organisms might not be as pathogenic as drug-sensitive strains; however, recent community outbreaks in Mississippi, New York, and Montana have demonstrated that some strains of drug-resistant tuberculosis may be very transmissible.
There are insufficient data on the pathogenicity of acquired drug-resistant and primary drug-resistant tubercle bacilli compared to drug-sensitive organisms. Operationally, health personnel must assume and act as if all drug-resistant patients are contagious.
The Center for Disease Control's surveillance studies of primary drug resistance and acquired drug resistance should be continued. Health departments of states and large cities should maintain registers of tuberculosis and should record information on drug resistance in the registers. At least annually, health departments should review the register of tuberculosis and report to the community an assessment of rates of primary and acquired drug resistance in the community and the state. As part of complete community surveillance, laboratories should be required to report drug-resistant isolates of tuberculosis to the health CHEST I 87 I 2 1 FEBRUARY, 1985 / Supphmnl department. Whenever two or more cases of tuberculosis occur with an identical pattern of drug resistance, a thorough investigation should be conducted by the health department to iden* a possible community outbreak. When possible community outbreaks are detected, consultation should be sought from appropriate health departments or the Center for Disease Control to ensure that appropriate actions for surveillance and containment are instituted.
Health departments should conduct intensive follow-up of contacts of drug-resistant cases. "Concentric-circle" epidemiologic investigation should be performed for each case, and investigation should be extended beyond the contacts in the immediate household. Detailed investigation of contacts always should be repeated when a patient's tuberculosis reactivates or develops drug-resistant organisms.
Sometimes noncompliant patients with drug-resistant disease refuse to cooperate with health departments and providers of medical care. Confinement of such totally uncooperative patients with sputumpositive tuberculosis is expensive and difficult and should only be used when directly observed therapy and other efforts to ensure compliance have failed. Public health laws should permit public health officials to confine such high-risk noncompliant patients, and facilities for confinement should be identified and financed with public funds. Public health laws also should permit continued confinement until successful completion of therapy.
Occasionally, patients develop disease with tubercle bacilli which are resistant to all antituberculosis medications and continue to have positive sputum. Unfortunately, such patients are potential spreaders of their drug-resistant disease. If cooperative, such patients may be confined at home with close monitoring by officials of the health department, particularly when the patients live alone or when others in the home are tuberculin-positive. Uncooperative, sputum-positive, totally drug-resistant patients should be isolated at public expense.
SUPERVISED THERAPY
Extensive data indicate that more than 95 percent of the patients undergoing initial treatment who complete their prescribed regimen can be treated successfully; however, this rate of success is rarely attained under a program's conditions. The major reason for this discrepancy is that a significant percentage of patients fail to take their medications as advised. In this regard, it needs to be emphasized that noncompliant patients cannot accurately be identified prospectively.
Recommendations and Rationale
Despite the studies which indicate that noncompliance cannot be predicted, it is the opinion of many program directors that a single, inner-city, unemployed alcoholic patient is more likely to be poorly compliant. Since many studies document that the patient's compliance is frequently overestimated, it is recommended that those patients who are expected to show themselves to be noncompliant with ingestion of medication should be treated such that this ingestion is directly observed. Others can be treated in an unsupervised fashion.
Increasing the number of patients in programs providing direct observation of ingestion of medication will temporarily raise the costs of the program; however, ultimately, the costs of programs to control tuberculosis will be markedly reduced as the fiequency of failure of treatment, with its attendant problems of drug resistance and rehospitalization, is reduced. In addition, programs employing directly supervised regimens of intermittent drugs may result in financial savings by using fewer doses of drugs and by obviating the need for monitoring the response to therapy (routine chest x-ray films and samples of sputum). Personnel who are not physicians or nurses should be used under a variety of circumstances to supervise and observe administration of medication.
A national registry of tuberculosis patients should be established. This registry could iden* drug resistance, along with location, health provider, and most recent bacteriologic, radiologic, and therapeutic status. Such a registry would be invaluable in the management of itinerant patients and in the evaluation of various programs to control tuberculosis. It is recognized that prior to implementation, certain legal, logistical, and financial problems would have to be solved.
There is concern that there will be insufficient numbers of adequately trained physicians to provide care for tuberculosis in the future. Enlightened and highly motivated graduates of specialized programs for training in tuberculosis and federally-funded service designees are growing fewer and older. It is suggested that this issue must be addressed in order to continue the progress that has been achieved in the control of tuberculosis in the United States and Canada. 
